Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Delaware Health News Online.
Press releases published on August 11, 2025
I-Mab Completes Enrollment in Planned Phase 1b Dose Expansion Study for Givastomig in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers
GlobeNewswire
·
August 11, 2025
Enrollment in the planned second dose expansion cohort completed ahead of expectations Topline results expected in Q1 2026 Positive Phase 1b dose escalation data presented at ESMO GI on July 2nd ROCKVILLE, Md., Aug. 11, 2025 (GLOBE NEWSWIRE) -- I-Mab ( …
FDA Clears IND for SEED Therapeutics’ RBM39 Degrader ST-01156
GlobeNewswire
·
August 11, 2025
• First Patient Dosing Expected in Q1 2026 • Clinical Trial to Prioritize Biomarker-Selected RBM39-Dependent Cancers KING OF PRUSSIA, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) -- SEED Therapeutics, Inc. (“SEED”), a clinical-stage biotechnology company …
Sionna Therapeutics Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 11, 2025
Announced positive Phase 1 data for SION-719 and SION-451 demonstrating both first-in-class NBD1 stabilizers were generally well tolerated and exceeded pharmacokinetic targets Initiation of Phase 2a proof-of-concept trial of SION-719 as an add-on to …
BioXcel Therapeutics to Participate in Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire
·
August 11, 2025
NEW HAVEN, Conn., Aug. 11, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that Vimal Mehta, Ph.D., CEO …
Medical Teams International Launches Campaign to Raise $1 Million USD by August 31
GlobeNewswire
·
August 11, 2025
Portland, Oregon USA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Medical Teams International, a global health and humanitarian relief organization, has launched “Rise to the Moment,” a fundraising campaign to help drive our urgent work to provide compassionate, …
Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry
GlobeNewswire
·
August 11, 2025
VANCOUVER, British Columbia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to- …
Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events
GlobeNewswire
·
August 11, 2025
STAFFORD, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in …
Belite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
August 11, 2025
Tinlarebant granted Breakthrough Therapy Designation for Stargardt disease (STGD1) by the U.S. Food and Drug Administration (FDA) DRAGON trial completion expected by Q4 2025 (including a three-month follow-up period) Enrollment completed with 529 subjects …
Nyxoah Announces Preliminary Results for the Second Quarter of 2025
GlobeNewswire
·
August 11, 2025
Nyxoah Announces Preliminary Results for the Second Quarter of 2025 Mont-Saint-Guibert, Belgium – August 11, 2025, 7:00am CET / 1:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops …
Nyxoah Annonce ses Résultats Préliminaires pour le Deuxième Trimestre 2025
GlobeNewswire
·
August 11, 2025
Nyxoah Annonce ses Résultats Préliminaires pour le Deuxième Trimestre 2025 Mont-Saint-Guibert, Belgique – 11 août 2025, 7h00 CET / 01h00 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une société de technologie médicale …